Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06641362 · ClinicalTrials.gov registry record
Ultra-High Frequency - Electrocardiogram (UHF-ECG) for the Diagnosis of Ventricular Electrical Dyssynchrony (VED)
A clinical trial of Heart Failure and Bradycardia, sponsored by VDI Technologies.
- Recruiting
- Registry status
- 360
- Enrollment target
- 9
- Study locations
NCT06641362: Recruiting study of Heart Failure and Bradycardia, sponsored by VDI Technologies.
NCT06641362 is a study of Heart Failure and Bradycardia that is actively recruiting participants, run by VDI Technologies. The registered enrollment target is 360 participants, below the 2,048-participant average among 397 other Heart Failure trials with a reported enrollment target (82% lower). The trial reports 9 study locations across 7 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06641362, a study of Heart Failure and Bradycardia, is actively recruiting participants, sponsored by VDI Technologies.
- RECRUITING
- Registry status
- 360 participants
- Enrollment target
- 9
- Study locations
Study Summary
The purpose of this study is to demonstrate the safety and effectiveness of the VDI UHF-ECG System in the diagnosis of ventricular dyssynchrony when compared to the 12-lead ECG in patients with bradycardia and heart failure indicated for pacemaker implantation.
Primary Outcome
Positive and negative predictive agreement between standard 12-lead ECG and UHF-ECG in discrimination of ventricular synchrony versus dyssynchrony with one recording per participant taken pre-procedure as evaluated by the core laboratory.
Conditions Studied
Interventions
- DEVICE Ultra High Frequency Electrocardiogram (UHF-ECG)
Study Locations (9)
Arizona
- Peak Heart and Vascular - Avondale
- Banner Medical Center - Mesa
Other
- St. Anne's University Hospital - Brno
- Catherina Ziekenhuis - Eindhoven
Illinois
- University of Chicago - Chicago
Minnesota
- Mayo Clinic - Rochester
Ohio
- Ohio State University - Columbus
Texas
- Baylor College of Medicine - Houston
Virginia
- University of Virginia - Charlottesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 360 participants |
| Start Date | 2025-03-18 |
| Est. Completion | 2026-05 |
What NCT06641362 shows while recruiting
NCT06641362 is an observational study that tracks outcomes without assigning an intervention. The registered 360 participants enrollment target is mid-sized for trials with a published cap, below the 2,048-participant average among 397 other Heart Failure trials with a reported enrollment target (82% lower).
The record links to 3 conditions, with Heart Failure appearing as the primary indexed condition, and to 1 intervention - of which Ultra High Frequency Electrocardiogram (UHF-ECG) is the first listed.
NCT06641362 lists 9 locations in 7 states (Arizona, Other, Illinois).
Frequently Asked Questions
What is clinical trial NCT06641362 about?
NCT06641362 is a clinical study titled "Ultra-High Frequency - Electrocardiogram (UHF-ECG) for the Diagnosis of Ventricular Electrical Dyssynchrony (VED)". The purpose of this study is to demonstrate the safety and effectiveness of the VDI UHF-ECG System in the diagnosis of ventricular dyssynchrony when compared to the 12-lead ECG in patients with bradycardia and heart failure indicated for pacemaker implantation.
What is the current status of trial NCT06641362?
This trial is currently recruiting. The enrollment target is 360 participants. The study started on 2025-03-18. Estimated completion is 2026-05.
What conditions does trial NCT06641362 study?
This clinical trial studies the following conditions: Heart Failure, Bradycardia, Ventricular Dysfunction.
What interventions are being tested in trial NCT06641362?
The interventions under investigation include: Ultra High Frequency Electrocardiogram (UHF-ECG) (DEVICE).
Who is sponsoring clinical trial NCT06641362?
This trial is sponsored by VDI Technologies, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06641362 being conducted?
This trial has 9 study locations across Arizona, Illinois, Minnesota, Ohio, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06641362's enrollment target sits among peer trials
360 123rd of 397 higher than 273 of 397 other Heart Failure trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Heart Failure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Early Feasibility Study of the NORM™ System in Heart Failure Patients (FUTURE-HFII)
RECRUITING · NA
-
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
RECRUITING · NA
-
iCardia4HF: Multi-component mHealth Intervention for Patients With Heart Failure
RECRUITING · NA
-
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients with Heart Failure Who Are Intolerant or Not Eligible for Treatment with Steroidal Mineralocorticoid Receptor Antagonists
RECRUITING · Phase 3
-
Circulating Markers That Underlie the Transition From Compensated Hypertrophy to Heart Failure
RECRUITING
-
Integration of Telemedicine and Home-Based Cardiac Rehabilitation: Feasibility, Efficacy, and Adherence
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02747836 · 360 participants
Ultrasound Analysis of Human Carpal Tunnel System
- NCT04089046 · 360 participants · NA
Telemedicine Enhanced Asthma Management - Uniting Providers for Teens (TEAM-UP for Teens)
- NCT04130503 · 360 participants · NA
The Recovery in Stroke Using PAP Study
- NCT04703166 · 360 participants
Tulane iPredict, Prevent Study to Evaluate the Progression of Atrial Myopathy.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI